| 10-Q | 2020-03-31 | Filed 2020-05-14 |
| 10-K | 2019-12-31 | Filed 2020-03-30 |
| S-1 | 2019-10-25 | Public Filing |
| 10-Q | 2019-09-30 | Filed 2019-11-13 |
| S-1 | 2019-08-07 | Public Filing |
| S-1 | 2019-07-03 | Public Filing |
| 10-Q | 2019-06-30 | Filed 2019-08-12 |
| 10-Q | 2019-03-31 | Filed 2019-05-10 |
| 10-K | 2018-12-31 | Filed 2019-02-14 |
| 8-K | 2020-07-20 | Officers, Other Events, Exhibits |
| 8-K | 2020-06-12 | |
| 8-K | 2020-05-14 | |
| 8-K | 2020-04-21 | |
| 8-K | 2020-04-01 | |
| 8-K | 2020-03-30 | |
| 8-K | 2020-03-19 | |
| 8-K | 2020-03-06 | |
| 8-K | 2019-12-05 | |
| 8-K | 2019-10-28 | |
| 8-K | 2019-10-22 | |
| 8-K | 2019-09-20 | |
| 8-K | 2019-09-20 | |
| 8-K | 2019-08-13 | |
| 8-K | 2019-08-12 | |
| 8-K | 2019-07-12 | |
| 8-K | 2019-04-05 | |
| 8-K | 2019-03-15 | |
| 8-K | 2019-01-30 | |
| 8-K | 2019-01-15 |
| Comps ($'000 TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Parallax Health Sciences (PRLX) | 41,922 | 280% | -5.4 | -333% | 2,373 | 7,209 | 82 | 229 | -7,914 | -7,871 | 42,507 |
| Sanuwave Health (SNWV) | 41,781 | 42% | -5.8 | -467% | 1,644 | 14,962 | 693 | 290 | -7,680 | -7,149 | 41,378 |
| ATI Nationwide Holding (ATIN) | 41,622 | -862.6 | -3,752% | 1 | 19 | 0 | 0 | -48 | -48 | 41,621 | |
| India Globalization Capital (IGC) | 40,759 | 2% | -5.1 | -16% | 32,887 | 1,645 | 6,297 | 141 | -5,284 | -5,207 | 26,696 |
| Portsmouth Square (PRSI) | 40,747 | 24% | 13.7 | 4% | 62,481 | 135,874 | 59,500 | 14,496 | 2,290 | 12,407 | 169,553 |
| Medovex (MDVX) | 40,687 | 75% | -3.7 | -66% | 17,580 | 8,020 | 6,498 | 4,897 | -11,616 | -10,904 | 40,342 |
| MJ Holdings (MJNE) | 40,433 | 31% | -12.8 | -27% | 11,993 | 5,152 | 779 | 240 | -3,278 | -3,125 | 39,929 |
| Barfresh (BRFH) | 40,406 | 56% | -16.8 | -60% | 6,592 | 4,566 | 3,782 | 2,137 | -3,950 | -2,523 | 42,352 |
| EPHS Holdings (STNN) | 40,182 | -65.5 | -21% | 3,196 | 2,664 | 0 | 0 | -658 | -638 | 41,794 | |
| Pharmacyte Biotech (PMCB) | 39,956 | -9.9 | -75% | 5,338 | 804 | 0 | 0 | -4,016 | -4,016 | 39,911 | |
| Guardion Health Sciences (GHSI) | 39,881 | 61% | -5.4 | -76% | 8,955 | 906 | 665 | 403 | -6,819 | -6,353 | 34,326 |
| Super League Gaming (SLGG) | 39,507 | 54% | -1.1 | -138% | 18,773 | 1,567 | 822 | 443 | -25,991 | -25,147 | 26,921 |
| Smith Midland (SMID) | 39,433 | 20% | 13.6 | 3% | 40,403 | 20,126 | 34,250 | 6,971 | 1,178 | 2,992 | 40,678 |
| Earth Science Tech (ETST) | 39,246 | 53% | -19.3 | -600% | 352 | 833 | 597 | 316 | -2,113 | -2,030 | 39,211 |
| Xspand Products Lab (XSPL) | 38,927 | 30% | -18.2 | -24% | 9,639 | 4,622 | 7,819 | 2,365 | -2,304 | -2,080 | 37,914 |
| First Choice Healthcare Solutions (FCHS) | 38,514 | 16.2 | 3% | 27,801 | 7,984 | 0 | 0 | 832 | 1,917 | 31,130 | |
| Echelon (ELON) | 38,425 | 55% | -8.2 | -17% | 28,010 | 6,437 | 31,601 | 17,474 | -4,655 | -4,090 | 33,505 |
| AIT Therapeutics (AITB) | 38,356 | -2.1 | -310% | 5,265 | 10,272 | 0 | 0 | -16,345 | -16,330 | 33,491 | |
| Protagenic (PTIX) | 38,275 | -42.3 | -313% | 287 | 651 | 0 | 0 | -899 | -899 | 37,998 | |
| Williams Industrial Services Group (WLMS) | 38,114 | 12% | 31.0 | 2% | 105,953 | 84,820 | 223,335 | 27,162 | 1,988 | 2,354 | 72,978 |
| Balance Sheet ($'000) | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Cash | 63 | 445 | 298 | 1,270 | 4,735 | 3,198 | 2,066 | 1,102 | 671 | 174 | 2,369 | 5,555 |
| Accounts Receivable | 2 | 2 | 2 | 54 | 73 | 57 | 30 | 17 | 28 | 15 | 36 | 22 |
| Inventory | 44 | 50 | 108 | 178 | 155 | 183 | 412 | 381 | 358 | 304 | 319 | 320 |
| PP&E | 277 | 277 | 283 | 312 | 324 | 419 | 461 | 552 | 584 | 589 | 643 | 747 |
| Assets | 262 | 643 | 513 | 3,878 | 7,370 | 5,916 | 4,865 | 3,886 | 3,681 | 3,971 | 5,698 | 8,955 |
| Accounts Payable | ||||||||||||
| Long-Term Debt | ||||||||||||
| Liabilities | 608 | 490 | 256 | 756 | 500 | 600 | 587 | 399 | 495 | 2,083 | 1,010 | 906 |
| Stockholders' Equity | 346 | 154 | 256 | 3,122 | 6,870 | 5,316 | 4,278 | 3,487 | 3,186 | 1,888 | 4,688 | 8,049 |
| Income Statement ($'000) | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Revenue | 56 | 60 | 63 | 259 | 193 | 221 | 294 | 243 | 261 | 161 | ||
| Cost of Revenue | 23 | 30 | 30 | 93 | 79 | 137 | 125 | 93 | 97 | 71 | ||
| Gross Profit | 33 | 30 | 33 | 166 | 114 | 133 | 169 | 149 | 164 | 90 | ||
| R&D | 10 | 16 | 106 | 128 | 160 | 89 | 5 | 29 | 78 | 32 | ||
| SG&A | 676 | 868 | 1,509 | 2,231 | 2,287 | 1,701 | 1,305 | 1,302 | 2,898 | 2,471 | ||
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Net Income | -669 | -856 | -1,584 | -2,196 | -2,333 | -1,810 | -2,148 | -1,385 | -3,048 | -2,385 | ||
| Cash Flow ($'000) | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Cash Operating | -446 | -578 | -1,489 | -1,354 | -1,071 | -864 | -586 | -1,908 | -1,695 | |||
| Cash Investing | 0 | -6 | -12 | -145 | -42 | -91 | -5 | -54 | -104 | |||
| Cash Financing | 828 | 436 | 4,967 | -38 | -19 | -9 | 94 | 4,156 | 4,986 | |||